WORK Medical Technology Group LTD (WOK)
NASDAQ: WOK · Real-Time Price · USD
1.810
+0.030 (1.69%)
Jan 28, 2026, 12:07 PM EST - Market open
WOK Revenue
WORK Medical Technology Group LTD had revenue of $4.54M in the half year ending March 31, 2025, a decrease of -49.58%. This brings the company's revenue in the last twelve months to $10.74M, up 8.89% year-over-year. In the fiscal year ending September 30, 2024, WORK Medical Technology Group LTD had annual revenue of $11.51M, down -15.18%.
Revenue (ttm)
$10.74M
Revenue Growth
+8.89%
P/S Ratio
0.20
Revenue / Employee
$46,904
Employees
229
Market Cap
2.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 11.51M | -2.06M | -15.18% |
| Sep 30, 2023 | 13.57M | -6.15M | -31.18% |
| Sep 30, 2022 | 19.71M | -26.15M | -57.02% |
| Sep 30, 2021 | 45.86M | -6.66M | -12.68% |
| Sep 30, 2020 | 52.53M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Venus Concept | 58.88M |
| STRATA Skin Sciences | 30.98M |
| Nuwellis | 8.17M |
| INVO Fertility | 6.94M |
| ENvue Medical | 2.69M |
| Catheter Precision | 730.00K |
| Tivic Health Systems | 482.00K |
WOK News
- 4 weeks ago - WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026 - GlobeNewsWire
- 4 weeks ago - WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer - GlobeNewsWire
- 5 weeks ago - WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025 - GlobeNewsWire
- 3 months ago - WORK Medical Technology Group LTD's Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation - GlobeNewsWire
- 3 months ago - WORK Medical Technology Group LTD Announces US$1 Million Equity Investment in Neologics Bioscience - GlobeNewsWire
- 3 months ago - WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025 - GlobeNewsWire
- 3 months ago - WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq - GlobeNewsWire
- 3 months ago - WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance - GlobeNewsWire